Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Hematology Unit

Ankara 06200

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling